Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts.
暂无分享,去创建一个
H. Mackay | J. Dijkstra | T. Bosse | L. Mileshkin | A. Leary | M. Brinkhuis | E. M. van der Steen-Banasik | V. Smit | S. D. de Boer | N. Horeweg | R. Nout | V. Koelzer | H. Nijman | C. Creutzberg | J. Jobsen | L. Lutgens | M. Powell | I. Jurgenliemk-Schulz | S. Roothaan | N. Singh | Sonali Andani | Sarah Fremond | J. Barkey Wolf | Sinéad Melsbach | Ina Jurgenliemk-Schulz
[1] T. Brinker,et al. Artificial intelligence for detection of microsatellite instability in colorectal cancer—a multicentric analysis of a pre-screening tool for clinical application , 2022, ESMO open.
[2] M. Hung,et al. Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study. , 2022, The Lancet. Digital health.
[3] M. Köbel,et al. Selection of endometrial carcinomas for p53 immunohistochemistry based on nuclear features , 2021, The journal of pathology. Clinical research.
[4] Dimitris N. Metaxas,et al. Genetic mutation and biological pathway prediction based on whole slide images in breast carcinoma using deep learning , 2021, npj Precision Oncology.
[5] H. Horlings,et al. DeepSMILE: Contrastive self-supervised pre-training benefits MSI and HRD classification directly from H&E whole-slide images in colorectal and breast cancer , 2021, Medical Image Anal..
[6] H. Mackay,et al. Tertiary lymphoid structures critical for prognosis in endometrial cancer patients , 2021, Nature Communications.
[7] B. Martin,et al. Deep learning model for the prediction of microsatellite instability in colorectal cancer: a diagnostic study. , 2021, The Lancet. Oncology.
[8] Cyrus Chargari,et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma , 2020, International Journal of Gynecological Cancer.
[9] Anne L. Martel,et al. Self supervised contrastive learning for digital histopathology , 2020, Machine Learning with Applications.
[10] R. Socher,et al. Deep learning-enabled breast cancer hormonal receptor status determination from base-level H&E stains , 2020, Nature Communications.
[11] K. Mertz,et al. Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer , 2020, Cancer Immunology Research.
[12] H. Putter,et al. Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] K. Sirinukunwattana,et al. Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning , 2020, Gut.
[14] Ming Y. Lu,et al. Data-efficient and weakly supervised computational pathology on whole-slide images , 2020, Nature Biomedical Engineering.
[15] Kaiming He,et al. Improved Baselines with Momentum Contrastive Learning , 2020, ArXiv.
[16] N. Razavian,et al. Predicting endometrial cancer subtypes and molecular features from histopathology images using multi-resolution deep learning models , 2020, bioRxiv.
[17] A. Madabhushi,et al. HistoQC: An Open-Source Quality Control Tool for Digital Pathology Slides. , 2019, JCO clinical cancer informatics.
[18] Jin Tae Kwak,et al. Hover-Net: Simultaneous segmentation and classification of nuclei in multi-tissue histology images , 2018, Medical Image Anal..
[19] H. Putter,et al. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial , 2018, The Lancet. Oncology.
[20] H. Putter,et al. Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts , 2016, Clinical Cancer Research.
[21] P. Pollock,et al. Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative , 2015, Modern Pathology.
[22] Michael S. Bernstein,et al. ImageNet Large Scale Visual Recognition Challenge , 2014, International Journal of Computer Vision.
[23] Steven J. M. Jones,et al. Integrated genomic characterization of endometrial carcinoma , 2013, Nature.
[24] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[25] S. Siesling,et al. Outcome of Endometrial Cancer Stage IIIA with Adnexa or Serosal Involvement Only , 2011, Obstetrics and gynecology international.
[26] H. Putter,et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial , 2010, The Lancet.
[27] S. Siesling,et al. Multicenter cohort study on treatment results and risk factors in stage II endometrial carcinoma , 2007, International Journal of Gynecologic Cancer.
[28] P. Koper,et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial , 2000, The Lancet.
[29] T. D. Hamilton,et al. Classification of Tumours , 1930, Edinburgh medical journal.